Pitney Pharmaust patents valuation - Kpax, page-12

It would seem so...hence my question. I wanted to understand the logic of 'we on hot copper forum know this is definitely worth many billions' vs industry experts (big pharma) not making a move (obviously they are not seeing the potential). Obviously, it is risk.

While I understand the optimism and enthusiasm I for one am not counting any chickens. It seems many believe this is a forgone conclusion but even Mr Sergio Duchini in his very recent interview talks about being 'realistic' and stressing the point that these things more often than not don't go the way it was hoped.

Not that it changes anything, as we are all in the game knowing the risks and of course potential rewards.

But it is strange to me that so many are willing to outright dismiss any 'early takeover' because this "certainty" this will be worth $10 per share in the near future. If big pharma offered $1-2 billion now, I think there is a good chance PAA drops off the ASX.